Skip to main content
. Author manuscript; available in PMC: 2011 May 10.
Published in final edited form as: Stat Biopharm Res. 2011 Feb 1;3(1):97–105. doi: 10.1198/sbr.2010.09044

Table 2.

Type I error rates for the unadjusted (R) and survival-adjusted (R*) range-based tests by tumor rate (π), shape of the incidence curve (γ1), number of historical control groups (k), and absence/presence of extra variation. All tests were based on a sample size of n=50 per group, with 70% of the animals (on average) surviving to the terminal sacrifice.

πa γ1 No extra variationb
Extra variationb
k=2 k=5 k=10 k=2 k=5 k=10
Unadjusted range-based test (R)
0.01 1.5 27.9 9.0 4.4 30.2 9.6 4.6
3.0 27.9 9.0 4.3 30.1 9.4 4.8
6.0 28.6 8.8 5.1 31.0 9.7 4.6
0.05 1.5 48.7 20.9 11.0 49.6 22.0 11.5
3.0 48.4 21.0 11.0 49.6 21.7 11.7
6.0 49.2 20.8 11.2 50.0 21.5 11.4
0.15 1.5 55.9 26.0 13.1 56.1 25.8 13.6
3.0 56.1 26.3 13.1 56.3 26.1 13.4
6.0 56.1 26.2 13.0 56.1 26.5 13.6
0.30 1.5 57.7 26.5 14.0 58.1 26.7 14.1
3.0 58.1 27.2 14.0 58.7 27.1 14.1
6.0 58.7 26.7 13.8 58.5 26.9 14.5
Poly-3 survival-adjusted range-based test (R*)
0.01 1.5 36.9 16.4 9.1 40.4 16.8 8.8
3.0 37.0 16.4 9.1 39.9 16.7 9.2
6.0 38.0 16.3 9.9 41.4 17.3 9.1
0.05 1.5 65.6 31.5 17.1 66.2 32.6 18.4
3.0 65.8 31.8 17.4 66.1 32.3 18.5
6.0 65.9 31.9 17.2 66.2 32.4 17.8
0.15 1.5 67.0 34.0 18.2 66.3 33.7 18.2
3.0 67.0 34.0 17.9 66.6 33.8 18.1
6.0 66.7 33.8 17.9 66.6 33.8 18.4
0.30 1.5 65.9 33.2 18.2 66.1 32.6 17.8
3.0 66.2 32.9 17.9 66.5 33.3 17.7
6.0 66.5 32.9 17.5 66.8 33.2 18.3
a

The mean tumor rate among the historical control groups (πh) equals the mean tumor rate in the current control group (πc) under the null hypothesis (H0: πh = πc = π).

b

The variance of the tumor rates among the historical control groups in the presence of extra variation is 20% larger than in the absence of extra variation.